Related Experiment Videos

Management of left ventricular diastolic heart failure: is it only blood pressure control?

Andrzej Koprowski1, Marcin Gruchala, Andrzej Rynkiewicz

  • 1Department of Cardiology, Medical University of Gdansk, Gdansk ul. Debinki 7, Poland.

Current Opinion in Cardiology
|June 18, 2009
PubMed

Insights

Diastolic heart failure (DHF) lacks proven therapies to improve survival. Current treatments for DHF are not well-supported, highlighting the need for new therapeutic strategies and comorbidity management.

Area of Science:

  • Cardiology
  • Heart Failure Research
  • Clinical Therapeutics

Background:

  • Diastolic heart failure (DHF) is a prevalent clinical condition.
  • There is a significant need for effective therapies for DHF.
  • Current treatment options for DHF lack robust evidence.

Purpose of the Study:

  • To review the current therapeutic landscape for diastolic heart failure.
  • To assess the efficacy of existing treatments in improving outcomes for DHF patients.
  • To identify unmet needs in DHF management.

Main Methods:

  • Review of existing clinical trials and therapeutic guidelines for DHF.
  • Analysis of data from comparative studies, including the Hong Kong DHF trial.
  • Evaluation of treatment effects on survival and morbidity in DHF.

Main Results:

  • No current treatment has demonstrated a significant improvement in survival for DHF patients.
  • The Hong Kong DHF trial showed no superior effect of ACE inhibitors or ARBs over each other in DHF.
  • Existing therapies, often adapted from systolic heart failure, lack proven benefit in DHF.

Conclusions:

  • Effective therapies for diastolic heart failure remain elusive.
  • Management should focus on screening and treating key comorbidities like hypertension, diabetes, and obesity.
  • Further research is urgently needed to develop and validate novel treatments for DHF to improve patient outcomes.
Abstract

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...